Ruan et al. reported that Sev exerts inhibitory effects on the growth, differentiation, and self-renewal of chronic myeloid leukemia (CML) CD34+ stem cells through suppression of the Wnt/β-catenin signaling pathway [62]. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.